Comparison of MRI and PET-CT in detecting the loco-regional recurrence of soft tissue sarcomas during surveillance
- 484 Downloads
To investigate the diagnostic performance of MRI and PET-CT for the detection of loco-regional recurrences after soft tissue sarcoma (STS) excision.
Materials and Methods
From Dec 2003 to Aug 2014, 394 patients with STSs, who were included in the electronic patient registry for initial or repeated surgery at our hospital, were retrospectively reviewed. We identified 152 patients who underwent regular postoperative follow-ups with both MRI and PET-CT, obtained within a 3 month period of each other. We analyzed differences in the performance of MRI and PET-CT for the diagnosis of loco-regional recurrences using McNemar’s test. The receiver-operating characteristic curves and calculations of the area under the curve were used.
Twenty patients were found to have a loco-regional recurrence after tumor excision. For MRI and PET-CT, the sensitivities were 90.0 and 95.0 %, and the specificities 97.7 and 95.5 %, respectively, with positive predictive values of 85.7 and 76.0 % and negative predictive values of 98.5 and 99.2 %, respectively. No significant difference was detected between the sensitivities of MRI and PET-CT (p = 0.125). The area under the receiver-operating characteristic curve for PET-CT (0.952) was not significantly greater than that for MRI (0.939; p = 0.6).
MRI of the area of interest is recommended for evaluation of tumor recurrence after surgical excision of STS. PET-CT was shown to be effective for detection of STS recurrence, and comparable to MRI. However, if PET-CT or MRI findings are inconclusive, the other modality may be helpful in differentiating tumor recurrence from post-therapeutic tissue change.
KeywordsSoft tissue sarcoma Recurrence Paired comparison Magnetic resonance imaging Positron emission tomography
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC; 2002.Google Scholar
- 9.National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Soft tissue sarcoma Version 2.2016 [cited 2016 Mar 17]. Available at http://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf.
- 10.Tagliafico A, Truini M, Spina B, et al. Follow-up of recurrences of limb soft tissue sarcomas in patients with localized disease: performance of ultrasound. Eur Radiol. 2015:1–7.Google Scholar
- 11.American College of Radiology (2015). ACR Appropriateness Criteria. Follow-up of Malignant or Aggressive Musculoskeletal Tumors [cited 2015 Jan 10]. Available via http://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/FollowupMalignantOrAggressiveMusculoskeletalTumors.pdf.
- 12.Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:iii102–12.Google Scholar